Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients

Cedar J. Fowler, Jennifer Dunlap, Darcy Troyer, Peter Stenzel, Elliot Epner, Richard Maziarz

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A single institution case series of adenovirus infections after allogeneic hematopoietic stem cell transplantation is presented to highlight the consideration for adenovirus infections as an etiology in patients with rapid hepatic or other sudden organ deterioration in the setting of apparent GVHD stabilization. The series also highlights that survival is limited with these infections often due in part to concomitant opportunistic infections. In addition, the pathophysiological events, such as GVHD and hepatic dysfunction, may complicate the clinical picture and delay therapy of an opportunistic infection. This is particularly true for adenoviral infections as they also have a distinct clinical picture in immunocompromised patients when compared to immune competent patients. Adenovirus infections also have the additional challenge that its treatment, cidofovir, has associated toxicities that can delay its administration. Recent developments has yielded an assay that can be used in the early detection and for serial determinations of adenovirus in patients with advanced GVHD, as well as a new therapeutic agent currently undergoing clinical trials.

Original languageEnglish (US)
Article number601548
JournalAdvances in Hematology
Volume2010
DOIs
StatePublished - 2010

Fingerprint

Adenoviridae Infections
Stem Cells
Opportunistic Infections
Transplants
Liver
Hematopoietic Stem Cell Transplantation
Immunocompromised Host
Infection
Adenoviridae
Therapeutics
Clinical Trials
Survival

ASJC Scopus subject areas

  • Hematology

Cite this

Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients. / Fowler, Cedar J.; Dunlap, Jennifer; Troyer, Darcy; Stenzel, Peter; Epner, Elliot; Maziarz, Richard.

In: Advances in Hematology, Vol. 2010, 601548, 2010.

Research output: Contribution to journalArticle

@article{0439da334e914c6fb4028114a4896c59,
title = "Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients",
abstract = "A single institution case series of adenovirus infections after allogeneic hematopoietic stem cell transplantation is presented to highlight the consideration for adenovirus infections as an etiology in patients with rapid hepatic or other sudden organ deterioration in the setting of apparent GVHD stabilization. The series also highlights that survival is limited with these infections often due in part to concomitant opportunistic infections. In addition, the pathophysiological events, such as GVHD and hepatic dysfunction, may complicate the clinical picture and delay therapy of an opportunistic infection. This is particularly true for adenoviral infections as they also have a distinct clinical picture in immunocompromised patients when compared to immune competent patients. Adenovirus infections also have the additional challenge that its treatment, cidofovir, has associated toxicities that can delay its administration. Recent developments has yielded an assay that can be used in the early detection and for serial determinations of adenovirus in patients with advanced GVHD, as well as a new therapeutic agent currently undergoing clinical trials.",
author = "Fowler, {Cedar J.} and Jennifer Dunlap and Darcy Troyer and Peter Stenzel and Elliot Epner and Richard Maziarz",
year = "2010",
doi = "10.1155/2010/601548",
language = "English (US)",
volume = "2010",
journal = "Advances in Hematology",
issn = "1687-9104",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients

AU - Fowler, Cedar J.

AU - Dunlap, Jennifer

AU - Troyer, Darcy

AU - Stenzel, Peter

AU - Epner, Elliot

AU - Maziarz, Richard

PY - 2010

Y1 - 2010

N2 - A single institution case series of adenovirus infections after allogeneic hematopoietic stem cell transplantation is presented to highlight the consideration for adenovirus infections as an etiology in patients with rapid hepatic or other sudden organ deterioration in the setting of apparent GVHD stabilization. The series also highlights that survival is limited with these infections often due in part to concomitant opportunistic infections. In addition, the pathophysiological events, such as GVHD and hepatic dysfunction, may complicate the clinical picture and delay therapy of an opportunistic infection. This is particularly true for adenoviral infections as they also have a distinct clinical picture in immunocompromised patients when compared to immune competent patients. Adenovirus infections also have the additional challenge that its treatment, cidofovir, has associated toxicities that can delay its administration. Recent developments has yielded an assay that can be used in the early detection and for serial determinations of adenovirus in patients with advanced GVHD, as well as a new therapeutic agent currently undergoing clinical trials.

AB - A single institution case series of adenovirus infections after allogeneic hematopoietic stem cell transplantation is presented to highlight the consideration for adenovirus infections as an etiology in patients with rapid hepatic or other sudden organ deterioration in the setting of apparent GVHD stabilization. The series also highlights that survival is limited with these infections often due in part to concomitant opportunistic infections. In addition, the pathophysiological events, such as GVHD and hepatic dysfunction, may complicate the clinical picture and delay therapy of an opportunistic infection. This is particularly true for adenoviral infections as they also have a distinct clinical picture in immunocompromised patients when compared to immune competent patients. Adenovirus infections also have the additional challenge that its treatment, cidofovir, has associated toxicities that can delay its administration. Recent developments has yielded an assay that can be used in the early detection and for serial determinations of adenovirus in patients with advanced GVHD, as well as a new therapeutic agent currently undergoing clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=77954600441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954600441&partnerID=8YFLogxK

U2 - 10.1155/2010/601548

DO - 10.1155/2010/601548

M3 - Article

C2 - 20672048

AN - SCOPUS:77954600441

VL - 2010

JO - Advances in Hematology

JF - Advances in Hematology

SN - 1687-9104

M1 - 601548

ER -